BioSpace News Archive

Drug Development

BMS, Synairgen Regroup After Trials Miss Primary Endpoints

Monday woes were shared by Bristol Myers Squibb and Synairgen, as their clinical trial candidates failed to perform as expected.

May 16, 2022
·
3 min read
·
Jazmine Colatriano M.S.
Researchers Pinpoint Important Biomarker for SIDS - Updated

Researchers released a study that has identified the first biochemical marker that could help detect babies more at risk of Sudden Infant Death Syndrome (SIDS) while they are alive.

May 16, 2022
·
2 min read
·
Rosemary Scott
Drug Development

Orna Proves Concept in Preclinical Oncology and DMD Models

Orna announced first-ever data from its lead isCAR program that validates both the technology and its LNP delivery platform. BioSpace spoke with ORNA CEO Tom Barnes.

May 16, 2022
·
3 min read
·
Heather McKenzie
Policy

Seagen CEO Resigns Following Domestic Violence Allegations

Clay Siegall resigned his role as president, CEO and a member of the board of directors of Seagen following domestic violence allegations. Roger Dansey will serve as interim CEO.

May 16, 2022
·
2 min read
·
Alex Keown
Drug Development

Exciting Advancements in Multiple Myeloma, Asthma and Alzheimer’s

Sanofi, AstraZeneca, Avillion and Diadem recently announced clinical results, providing positive news for patients with multiple myeloma, asthma and Alzheimer’s disease.

May 16, 2022
·
3 min read
·
Hannah Chudleigh
Drug Development

ASGCT Opening Highlights Advancements, New Therapies

The American Society of Gene & Cell Therapy (ASGCT) Annual Meeting kicked off Monday with multiple presentations highlighting the potential of new treatments for a myriad of diseases.

May 16, 2022
·
5 min read
·
Alex Keown
Deals

KemPharm Acquires Majority of Orphazyme Assets Under In-Court Restructuring

Orphazyme has several products with potential, with biopharma company KemPharm acquiring nearly all of the company’s assets and operations.

May 16, 2022
·
3 min read
·
Hannah Chudleigh
Business

Sofinnova Nets $1B+ from Apollo to Accelerate Biotech Growth

Sofinnova Partners announced on Monday that it entered into a long-term strategic and financial partnership with Apollo to expand its presence in the life sciences.

May 16, 2022
·
2 min read
·
Hayley Shasteen
Business

AbbVie, AstraZeneca See Value in what Cugene, Proteros Have to Offer

Cugene and AbbVie came together on autoimmune diseases and cancer, while Proteros and AstraZeneca expanded their collaboration on epigenetic cancer drugs.

May 16, 2022
·
3 min read
·
Mark Terry
Researchers Continue to Build Toolbox as May Recognizes ALS

In honor of ALS Awareness Month, BioSpace spoke with leading researchers like Dr. Matthew Harms of Columbia University and Drs. Howard Berman and Stanley Appel at Coya Therapeutics.

May 16, 2022
·
6 min read
·
Heather McKenzie